U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H18NO9.Na
Molecular Weight 331.2517
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM N-ACETYL-.BETA.-NEURAMINATE

SMILES

[Na+].[H][C@]1(O[C@@](O)(C[C@H](O)[C@H]1NC(C)=O)C([O-])=O)[C@H](O)[C@H](O)CO

InChI

InChIKey=QKFTYFYIYXTFBX-BKSOAOGQSA-M
InChI=1S/C11H19NO9.Na/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13;/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19);/q;+1/p-1/t5-,6+,7+,8+,9+,11-;/m0./s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C11H18NO9
Molecular Weight 308.2619
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Sodium aceneuramate is a sodium salt of aceneuramic acid (sialic acid). It is an effective inhalant expectorant. Inhalation of sodium aceneuramate repaired inflammation in the airway, and caused bronchitic rabbits to produce sputa with a low viscosity, similar to normal air-way secretions. Sodium aceneuramate protected the mucociliary transport impaired bycigarette smoke in a dose-dependent manner. The results suggest that sodium aceneuramate may participate in the defense mechanism in the airway against irritant gases. Sodium aceneuramate inhibited bronchial anaphylaxis and the release of histamine into bronchoalveolar lavages. Sodium aceneuramate has an action which elevates the viscoelasticity of secretions in the respiratory tract.

Approval Year

PubMed

PubMed

TitleDatePubMed
Tracheobronchial mucociliary clearance and alveolar epithelial permeability measured by PET with 18FDG powder.
1990 Mar-Apr
Current opinion of muco-active drug research: strategies and problems.
1998 Feb

Sample Use Guides

Sodium aceneuramate was administered at 2 mg, b.i.d. for 7 days by inhalation to ten patients with bronchiectasis, chronicbronchitis, diffuse panbronchiolitis and other respiratorydiseases that cause sputa.
Route of Administration: Respiratory
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:39:10 GMT 2023
Edited
by admin
on Sat Dec 16 07:39:10 GMT 2023
Record UNII
C4WSL8GQZ2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM N-ACETYL-.BETA.-NEURAMINATE
Common Name English
.BETA.-NEURAMINIC ACID, N-ACETYL-, SODIUM SALT (1:1)
Common Name English
SODIUM ACENEURAMATE [JAN]
Common Name English
D-GLYCERO-.BETA.-D-GALACTO-2-NONULOPYRANOSONIC ACID, 5-(ACETYLAMINO)-3,5-DIDEOXY-, MONOSODIUM SALT
Common Name English
KI 111
Code English
.BETA.-NEURAMINIC ACID, N-ACETYL-, MONOSODIUM SALT
Common Name English
KI-111
Code English
Code System Code Type Description
CAS
92413-99-5
Created by admin on Sat Dec 16 07:39:10 GMT 2023 , Edited by admin on Sat Dec 16 07:39:10 GMT 2023
PRIMARY
EPA CompTox
DTXSID601032359
Created by admin on Sat Dec 16 07:39:10 GMT 2023 , Edited by admin on Sat Dec 16 07:39:10 GMT 2023
PRIMARY
PUBCHEM
23662231
Created by admin on Sat Dec 16 07:39:10 GMT 2023 , Edited by admin on Sat Dec 16 07:39:10 GMT 2023
PRIMARY
FDA UNII
C4WSL8GQZ2
Created by admin on Sat Dec 16 07:39:10 GMT 2023 , Edited by admin on Sat Dec 16 07:39:10 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE